A flurry of fresh insider filings this week shows executives putting real money on the table — while others quietly cashed out.
Cluster buying leads the headlines. APTV saw three insiders buy in August. CEO Kevin Clark filed an $2.5M purchase on August 11. Director Paul Meister added $5M on August 6. Together, the Aptiv team committed over $8M. The auto-tech firm's stock sits near multi-year lows.
PFE told a similar story. CEO Albert Bourla filed a $1M purchase on August 12. Two independent directors each bought nearly $1M the same week. Three insiders buying in the same week at a company of Pfizer's size is unusual and worth watching.
The biggest single buy came from BSX. CEO Michael Mahoney filed a $9M purchase on August 5 — 186,240 shares at roughly $48 each. A director added another $228K the same week. That's the largest US CEO buy in this period.
BORR Drilling's founder and chairman Tor Olav Troim filed a $6M purchase on August 14. An independent director added $500K the same day. The offshore driller's stock has been under pressure this year.
On the sell side, CEO Mark Tarr sold $21.5M worth of shares on August 10. founder Bahram Akradi filed a $19.5M sale on August 4. CEO Joaquin Duato sold $10.8M on August 7.
The contrast is clear. Medical device and energy insiders are buyers. Consumer and healthcare services CEOs are taking profits.
ORTEX Market Intelligence content is generated by AI from a snapshot of ORTEX's proprietary data. Content is informational only and does not constitute investment advice.
